Loading organizations...
Loading organizations...
Oncology drug development company focusing on immune cancer treatments.
KYinno has raised $51.1M across 2 funding rounds.
KYinno has raised $51.1M in total across 2 funding rounds.
KYinno has raised $51.1M in total across 2 funding rounds.
KYinno's investors include China Everbright, ZhenFund, Yishang Huicheng, Yuanhui Chuangtou.
KYinno has raised $51.1M across 2 funding rounds. Most recently, it raised $35.4M Series B in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 15, 2025 | $35.4M Series B | China Everbright | |
| Nov 29, 2021 | $15.7M Series A | ZhenFund | Yishang Huicheng, Yuanhui Chuangtou |